New England Journal of Medicine· 2018Q1
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- 1,438citations
- Q1SCImago
- 2018year
Short summary
Nusinersen treatment improved motor function by a mean of 4.0 points on the HFMSE scale at 15 months compared to a 1.9-point decrease in the sham group (n=126), a significant difference of 5.9 points.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Genetics
GeneticsMedicine